[{"NetIncomeLoss_1_Q2_USD":-18999000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":5.18,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":95946000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.011,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.011,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-580000.0,"Depreciation_2_Q2_USD":100000.0,"Depreciation_1_Q2_USD":100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2402370.0,"OtherAssets_0_Q2_USD":468000.0,"AssetsCurrent_0_Q2_USD":311589000.0,"LongTermDebt_0_Q2_USD":7396000.0,"LongTermDebtCurrent_0_Q2_USD":7396000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":404000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5218409.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4815000.0,"NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_Q2_USD":-580000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":5.93,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_0_Q2_USD":233000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.742,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.65,"ShareBasedCompensation_2_Q2_USD":1995000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":2.25,"Assets_0_Q2_USD":313166000.0,"CommonStockSharesIssued_0_Q2_shares":38865986.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":62000.0,"DeferredRevenue_0_Q2_USD":15726000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1086000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.952,"CommitmentsAndContingencies_0_Q2_USD":null,"ResearchAndDevelopmentExpense_1_Q2_USD":13554000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":5.18,"EarningsPerShareBasic_2_Q2_USD":-1.39,"EarningsPerShareBasic_1_Q2_USD":-0.49,"TemporaryEquityLiquidationPreference_0_Q2_USD":0.0,"PaymentsOfFinancingCosts_2_Q2_USD":17256000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":750367.0,"AccountsReceivableNetCurrent_0_Q2_USD":217000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":9254000.0,"CommonStockValue_0_Q2_USD":4000.0,"NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_Q2_USD":-24351000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":95000.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":275119000.0,"DeferredRevenueNoncurrent_0_Q2_USD":13040000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_2_Q2_USD":1000000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":38813865.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":23660559.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5618000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":10840000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":30919.0,"PaidInKindInterest_2_Q2_USD":540000.0,"Liabilities_0_Q2_USD":30738000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1143000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":-18999000.0,"IncomeLossFromContinuingOperations_2_Q2_USD":-32944000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":105000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":2177000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":304389000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":21312000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":326000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":35369.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":244000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1203000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24351000.0,"LiabilitiesCurrent_0_Q2_USD":17698000.0,"DeferredRevenueCurrent_0_Q2_USD":2686000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":16669000.0,"AccountsPayableCurrent_0_Q2_USD":2250000.0,"NonoperatingIncomeExpense_2_Q2_USD":-1878000.0,"NonoperatingIncomeExpense_1_Q2_USD":-153000.0,"InterestExpense_2_Q2_USD":848000.0,"InterestExpense_1_Q2_USD":190000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":304389000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6983000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.73,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.73,"ProceedsFromStockOptionsExercised_2_Q2_USD":126000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_2_Q2_USD":100000.0,"NetIncomeLoss_2_Q2_USD":-32944000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1109000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":73749000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":208000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":111206.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":5190989.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.01,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":304389000.0,"AdditionalPaidInCapital_0_Q2_USD":414514000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":468000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":95946000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":422000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q2_USD":100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.006,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":41654.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":1086000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-869000.0,"OperatingIncomeLoss_2_Q2_USD":-31066000.0,"OperatingIncomeLoss_1_Q2_USD":-18846000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":218500000.0,"IncreaseDecreaseInAccruedSalaries_2_Q2_USD":-325000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":1300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":1200000.0,"InvestmentIncomeInterest_2_Q2_USD":55000.0,"InvestmentIncomeInterest_1_Q2_USD":37000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":8.11,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.13,"LiabilitiesAndStockholdersEquity_0_Q2_USD":313166000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2398000.0,"PreferredStockSharesAuthorized_0_Q2_shares":40000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1995000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1203000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":250188000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-132090000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":-0.49,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":-1.39,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5190989.0,"DebtInstrumentCarryingAmount_0_Q2_USD":7500000.0,"CommonStockSharesOutstanding_0_Q2_shares":38835067.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":580000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":114000.0,"OperatingExpenses_1_Q2_USD":19172000.0,"OperatingExpenses_2_Q2_USD":32152000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1353000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":30421.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":16300000.0,"StockholdersEquity_0_Q2_USD":282428000.0,"ConversionOfStockAmountConverted1_2_Q2_USD":210810000.0,"Ticker":"RXDX","CIK":"1718852","name":"PROMETHEUS BIOSCIENCES, INC.","OfficialName":"Prometheus Biosciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1194957334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210811"}]